Study shows KP.2 Covid variant dominant in India
The KP.2 variant has become the dominant SARS-CoV-2 variant in India, particularly in Maharashtra, according to a study on Saturday.
The KP.2 variant has become the dominant SARS-CoV-2 variant in India, particularly in Maharashtra, according to a study on Saturday.
According to data from the Health Ministry, the death toll rose to 5,33,332 as four more succumbed to the disease.
The lateral flow immunoassay (LFIA) could prove an efficient substitute to RT-PCR tests.
The interactions between the receptor-binding domain (RBD) of coronavirus spike proteins and their host receptor are among the best systems for understanding coronavirus evolution.
Usually protein levels in the body are stable, but they found a dramatic difference in levels of some of the proteins up to six weeks following infection, suggesting disruption to a number of important biological processes.
The book titled "What Really Happened in Wuhan: the Cover-Ups, the Conspiracies and the Classified Research" is written by Australian investigative journalist Sharri Markson.
Fenofibrate is an oral drug currently used to treat conditions such as high levels of cholesterol and lipids (fatty substances) in the blood.
Until now, Delhi had to depend on the National Centre for Disease Control (NCDC) for verification of a new Covid variant noticed in the city's hospitals.
In the study, the team turned to single-cell RNA sequencing, which identifies which of roughly 20,000 genes are "on" in individual cells. They found that only a tiny percentage of human respiratory and intestinal cells, often well below 10 per cent, make both ACE2 and TMPRSS2.
Prof (Dr) Jagat Ram, director of the apex institute, told The Statesman that genome sequencing of 60 samples sent by the PGI revealed that 70 per cent carried the UK variant, 20 per cent had 681 H mutant while one sample was found to be infected with the double mutant of the coronavirus.
